Skip to main content
SpringerLink
Log in

Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: Value of measurement in diagnosis and treatment

  • Controversies in Gastroenterology
  • Published:
The American Journal of Digestive Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Verner JV, Morrison AB: Islet cell tumors and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 117:374–380, 1958

    Google Scholar 

  2. Verner JV, Morrison AB: Endocrine pancreatic islet disease with diarrhea. Arch Intern Med 133:492–500, 1974

    Google Scholar 

  3. Kraft AR, Tomkins RK, Zollinger RM: Recognition and management of the diarrheaal syndrome caused by non-B islet cell tumors of the pancreas. Am J Surg 119:163–170, 1970

    Google Scholar 

  4. Bloom SR, Polak JM, Pearse AGE: Vasoactive intestinal peptide and watery diarrhea syndrome. Lancet 2:14–16, 1973

    Google Scholar 

  5. Barbezat GO, Grossman MI: Intestnal secretion...stimulation by peptides. Sciences 1974:422–423, 1971

    Google Scholar 

  6. Said SI, Mutt V: Isolation from porcine intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem 28:199–204, 1972

    Google Scholar 

  7. Sanzenbacker LJ, Mekhjian HS, King DR, Zollinger RM: Studies on the potential role of secretin in the islet cell tumor diarrhogenic syndrome. Ann Surg 176:394–402, 1972

    Google Scholar 

  8. Said SE, Mutt V: Potent peripheral and splenic vasodilator peptide from normal gut. Nature 225:863–864, 1970

    Google Scholar 

  9. Bloom SR, Polak JM: The role of VIP in pancreatic cholera Gastrointestinal Hormones. JC Thompson (ed) Austin, University of Texas Press, 1975, pp 635–642

    Google Scholar 

  10. Schwartz CJ, Kimberg DV, Sheerinke V, Field M, Said SI: Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa. J Clin Invest 54:536–544, 1974

    Google Scholar 

  11. Modlin IM, Bloom SR, Mitchell SI: The role of VIP in diarrhea. Gut 18:A418, 1977

    Google Scholar 

  12. Swift PGF, Bloom SR, Harris F: Watery diarrhea and ganglioneuroma with secretion of vasoactive intestinal peptide. Arch Dis Child 50:896–899, 1975

    Google Scholar 

  13. Modlin IM, Mitchell SJ, Bloom SR: The systemic release and pharmocokinetics of VIP in gut hormones. Gut Hormones. SR Bloom (ed). Churchill Livingstone, Edinburgh, 1978, pp 470–474

    Google Scholar 

  14. Fairclough PD, Bloom SR, and Mitchell SR: Plasma VIP in ulcerative colitis. Lancet 1:964, 1976

    Google Scholar 

  15. Elias E, Mitchell SJ, Bloom SR: Vasoactive intestinal peptide in cirrhosis. Lancet 2:1312, 1975

    Google Scholar 

  16. Gagel RF, Constanza ME, Delellis RA, Norton RA, Bloom SR, Miller HH, Ucci A, Nathanson L: Streptozotocin treated Verner-Morrison syndrome, plasma vasoactive intestinal peptide and tumor response. Arch Intern Med 136:1429–1435, 1976

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Royal Postgraduate Medical School, Hammersmith Hospital, London, UK

    S. R. Bloom MA, MB, BChir, MRCP

Authors
  1. S. R. Bloom MA, MB, BChir, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bloom, S.R. Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: Value of measurement in diagnosis and treatment. Digest Dis Sci 23, 373–376 (1978). https://doi.org/10.1007/BF01072425

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01072425

Keywords

Search

Navigation